ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker

Abbott Laboratories, Inc. (ABT) has completed the world's first-in-human leadless left bundle branch area pacing (LBBAP) procedures. The landmark procedures were part of the prospective Leadless CSP (Conduction System Pacing) feasibility study, which evaluated the acute safety and performance of the company’s investigational AVEIR CSP leadless pacemaker system.The latest development is expected to strengthen Abbott’s Cardiac Rhythm Management business, part of the Medical Devices segment.ABT Stock’s Likely ...